News – Page 548 – Endpoints News

Sandrock’s first month at Voyager sours as shares crumble on Levin, Paul’s move to step off the board

4 years ago

Will a biotech rival finally shake up AbbVie's $2B Botox cosmetic franchise? Revance will find out soon

4 years ago

Bayer plucks another oncology exec away from GlaxoSmithKline as it continues prostate cancer push

4 years ago

Moving on from Usama Malik's insider trading imbroglio, Fore resets at the top; Takeda spinout turns to Neurana CEO ...

4 years ago

FDA's ODAC votes unanimously that future PI3K inhibitors should include randomized data for blood cancers

4 years ago

Louisiana AG sues UnitedHealth Group subsidiaries over fraud allegations in drug pricing case

4 years ago

Crowded rheumatoid arthritis category gets JAK reality check, while TNF stalwarts continue to dominate: study

4 years ago

Eli Lilly and Boehringer Ingelheim urge women to become their own heart health advocates in new campaign

4 years ago

Biotech, academic leaders encourage FDA to consider T-cell assessment in Covid-19 vaccine trials

4 years ago

Harvard researchers call on Congress to clean up pharma companies' mess of restrictions on contract pharmacies under ...

4 years ago

Another new manufacturing site for NC; BioCentriq acquired by South Korean company

4 years ago

How Novartis assesses a drug's probability of success prior to the pivotal trial

4 years ago

Seagen to build manufacturing site from ground up near Washington home

4 years ago

Catalent drops $350M to expand Indiana site that includes Moderna-dedicated line

4 years ago

Following BeiGene, Zai Lab changes auditors amidst SEC threat of delisting

4 years ago

Sanofi offloads two late-stage drugs to virtually unknown neuro and psychedelic biotech

4 years ago

FDA signs off on Gilead's massive new CAR-T manufacturing site in Maryland

4 years ago

Orasis will ship its Vuity eye drop competitor to the FDA later this year with two PhIII wins

4 years ago

Drugs containing nanomaterials: FDA finalizes 2017 guidance with several changes

4 years ago

Prescription drug use surged last year — but IQVIA doesn't expect that to last

4 years ago

Reify Health thinks clinical trials can be representative by 2030 — and it’s secured the capital to help partners ...

4 years ago

Synthetic biology biotech nets three-hit combo in new financing, Bristol Myers deal and first CSO

4 years ago

AstraZeneca showcases 83% risk reduction for long-acting Covid-19 antibody at 6-month analysis

4 years ago

Still struggling to get an EUA, Novavax paints early rosy picture of combo Covid-19/flu vaccine

4 years ago

First page Previous page 545 546 547548549 550 551 Next page Last page